These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19466541)

  • 21. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
    Wang G; Wei LN; Loh HH
    J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.
    Chen Y; Xu J; Borowicz S; Collins C; Huo D; Olopade OI
    BMC Cancer; 2011 Jun; 11():246. PubMed ID: 21668996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.
    Peng DF; Razvi M; Chen H; Washington K; Roessner A; Schneider-Stock R; El-Rifai W
    Gut; 2009 Jan; 58(1):5-15. PubMed ID: 18664505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
    Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
    World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
    Hambach L; Ling KW; Pool J; Aghai Z; Blokland E; Tanke HJ; Bruijn JA; Halfwerk H; van Boven H; Wieles B; Goulmy E
    Blood; 2009 Mar; 113(12):2715-22. PubMed ID: 19096014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
    Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
    Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK; Zhan Z; Bates SE
    Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.
    Bianco C; Castro NP; Baraty C; Rollman K; Held N; Rangel MC; Karasawa H; Gonzales M; Strizzi L; Salomon DS
    J Cell Physiol; 2013 Jun; 228(6):1174-88. PubMed ID: 23129342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.
    Zhang B; Xiang S; Zhong Q; Yin Y; Gu L; Deng D
    Hum Gene Ther; 2012 Oct; 23(10):1071-81. PubMed ID: 22738793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites.
    Chen C; Yang MC; Yang TP
    J Biol Chem; 2001 Jan; 276(1):320-8. PubMed ID: 11013250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
    Yuan BZ; Durkin ME; Popescu NC
    Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter.
    Butcher DT; Mancini-DiNardo DN; Archer TK; Rodenhiser DI
    Int J Cancer; 2004 Sep; 111(5):669-78. PubMed ID: 15252835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
    Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
    BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.